New Drug for Colorectal Cancer Shows Promise in Phase II Trial
New Drug for Colorectal Cancer Shows Promise in Phase II Trial
Filed under: drug treatment news articles
“Our results show that TAS-102 has a promising efficacy and an easily manageable safety profile for a group of patients who have virtually no other treatment options available to them,” said Yoshino. … Email me when someone comments on this article.
Read more on Cancer Network
Josh Sale, Ryan Brett suspended for drug violations | NW Briefs
Filed under: drug treatment news articles
Former Seattle-area high-school baseball stars Josh Sale and Ryan Brett were suspended 50 games for violating the Minor League Drug Prevention and Treatment Program. By Times news … Show comments. No comments have been posted to this article.
Read more on The Seattle Times
Merck's Blockbuster Drug Januvia And Its Competitors
Filed under: drug treatment news articles
Since DPP-4 inhibitors only enhance the body's own ability to release insulin and regulate blood glucose, these drugs can only treat type 2 diabetes. Their effect is …. I have no business relationship with any company whose stock is mentioned in this …
Read more on Seeking Alpha
Nanomedicines: Changing The Way We Treat Cancer
• Solution: Engineer new drug formulations to harness Working Hypothesis for Phase II Clinical Trial Success of The Promise of Cancer Nanomedicines ?Deliver potent anti-cancer agents directly to the site of … Document Retrieval
Alchemia’s Cancer Treatment Shows Early Promise In Lung …
Alchemia’s Cancer Treatment Shows Early Promise in Lung Cancer Trial patented HyACT® technology to target the anti-cancer drug irinotecan to the An earlier Phase II study in colorectal cancer with HA-Irinotecan showed a statistically significant … Get Document
Conference Digest
Was higher in colorectal cancer started phase–II trials with the drug, which was seen to be relatively safe and efficacious in the phase-I trial. Bevacizumab imaging system detects earlier tumours Attaching the anti-cancer drug bevacizumab to a radioactive trac-er shows promise as a new imaging … Fetch Here
No Slide Title
Sufficient” clinical promise Must also pay attention to toxicity Phase I Trial Design : Non-Cytotoxic Agents – Examples Pre-clinically define target drug if you are planning a new combination for a phase II trial patients with advanced colorectal cancer and liver metastases: results from two phase … Content Retrieval
Joint Annual Research Report 2009/10 The Royal Marsden NHS …
Shows Promise in Ovarian Cancer 19 Finding Breast Cancer Genes 23 New Treatments for Melanoma to exhibit great promise in Phase I trials. The Phase II trials of this drug have following a pivotal trial in colorectal cancer … View This Document
COLORECTAL CANCER RESEARCH UPDATES
Regorafenib Shows Promise Against Metastatic Colorectal Cancer 8. Lactate Dehydrogenase Levels May be a Predictor of Avastin’s Efficacy in First Line Therapy 9. Quebec-based Phase II Clinical Trial colon cancer, according to a new study that bolsters previous research on the drug by … View Doc
A Bringing Gene Therapy To Life – T …
5 Product Pipeline Phase III TRIST trial ongoing Phase II/III QUASAR trial preparation Phase IIa trials completed Renal cancer Colorectal cancer (post adjuvant) Colorectal equivalent’ therapy • First 12-month assessment shows Gene-based treatments potentially hold the most promise.” … Read Full Source
Molecular Cancer Therapeutics
Receptors shows promise as cancer therapy A false positive phase II trial will result in an inactive drug Investigational New Drugs. Dr. Eckhardt holds peer-reviewed funding for early clinical trials, mentoring, and colorectal cancer research and has conducted numerous phase I and II … Read Here
COLORECTAL CANCER RESEARCH
The AFFIRM Phase II clinical trial is Drug May Have Utility in Treating Colorectal Cancer (Apr.26/11) A new study from the randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapy. 18. How Inflammation Can Lead to Cancer (Apr.19/11) A new study shows how … Doc Viewer
Circadian Technologies
A dry-eye disease indication shows preclinical promise colorectal cancers are promising initial indications and likely Phase II trial indications. Dry-eye disease – a strong new indication for VGX-100 The US VGX-100 Phase I trial has two arms with 40 late stage cancer patients in total. … Get Document
Design And Analysis Of Phase I Clinical Trials In Cancer Therapy
Sufficient” clinical promise Must also pay attention to toxicity Phase I Trial Design : Non-Cytotoxic Agents – Examples Pre-clinically define target drug if you are planning a new combination for a phase II trial patients with advanced colorectal cancer and liver metastases: results from two phase … View Document
Niiki Pharma Breaks New Ground With Novel Cancer Therapy
A first-in-man cancer therapy in development by Niiki Pharma Inc. shows promise in targeting a new Niiki Pharma recently completed a Phase I trial and has determined the dose for a Phase II trial. non-small cell lung cancer, sarcoma, colorectal and c ancer of unknown … Content Retrieval
Update Analysis
W. Black once put it, “the most fruitful basis for the discovery of a new drug is to shows you how to save Pharmaprojects searches for future use. lidomide is also currently in a Phase II/III trial in 210 colorectal cancer patients in combination with other … Access Document
PRO – PHARMACEUTICALS (PRW)
Orphan drug status filed with FDA for cholangiocarcinoma 1Q07 Phase II, front line colon cancer trial: Interim or metastatic colorectal cancer. We believe this further validates the safety and promise of DAVANAT. The Company has not initiated the Phase tumors and a Phase II colorectal cancer trial … Document Viewer